Torquil Watt is an expert in patient-reported outcomes (PRO) research and a clinically working endocrinologist at Copenhagen University Hospital Herlev-Gentofte.
As part of Ulla Feldt-Rasmussen’s research group in Copenhagen, Torquil developed the ThyPRO questionnaire, measuring quality of life of patients with benign thyroid diseases and later the short-form ThyPRO-39. The former formed the basis for his PhD in 2007 and the latter for his Doctor of Science in 2017. This major piece of scientific work was performed in close collaboration with Laszlo Hegedüs’ group in Odense.
Scientifically, Torquil has worked with the development of scientifically valid measures of patient-reported outcomes for more than 20 years. Initially with validation of generic measures, primarily the SF-36 Health Survey.
The ThyPRO instruments are among the most thoroughly validated condition-specific instrument, regardless of disease area. It is currently available in validated versions in 22 languages and used in >100 ongoing clinical studies worldwide.
Torquil’s current research is focused on application of ThyPRO in clinical studies, including large-scale RCT’s of selenium supplementation. And on further methodological development of PRO science, including application of multiple momentary assessments, the so-called ‘ecological momentary assessments’, EMA.